Skip to main content

Aveanna Healthcare Holdings, Inc.

For the period ended Apr 4, 2026. Filed May 14, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Apr 4, 2026 · Filed May 14, 2026

AVAH$13.19-0.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows for the

AVEANNA HEALTHCARE HOLDINGS INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
(Unaudited)
For the three-month periods ended
April 4, 2026March 29, 2025
Cash Flows From Operating Activities:
Net income$41,653$5,193
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization3,0442,594
Amortization of deferred debt issuance costs9651,646
Reduction in carrying amount of operating lease right of use assets4,6074,352
Non-cash share-based compensation4,14710,996
(Gain) loss on disposal or impairment of licenses, property and equipment, and software(24)166
Fair value adjustments on interest rate derivatives64711,602
Deferred income taxes-612
Changes in operating assets and liabilities, net of impact of acquisitions:
Patient accounts receivable(19,327)(29,641)
Prepaid expenses(2,857)(2,433)
Other current and long-term assets4,726(646)
Accounts payable and other accrued liabilities2,545(5,972)
Accrued payroll and employee benefits(30,724)(1,752)
Insurance reserves3,7431,873
Operating lease liabilities(4,925)(4,771)
Other current and long-term liabilities(3,871)(2,451)
Net cash provided by (used in) operating activities4,349(8,632)
Cash Flows From Investing Activities:
Purchases of property and equipment, and software(4,557)(2,348)
Net cash used in investing activities(4,557)(2,348)
Cash Flows From Financing Activities:
Payments for shares withheld to cover employee taxes on vesting of restricted stock(478)(1,677)
Proceeds from exercise of options269-
Proceeds from employee stock purchase plan-1,791
Principal payments on term loans(3,312)(2,300)
Principal payments on notes payable(2,406)(2,763)
Settlements with interest rate swap counterparties2,1493,135
Net cash used in financing activities(3,778)(1,814)
Net change in cash and cash equivalents(3,986)(12,794)
Cash and cash equivalents at beginning of period193,26084,288
Cash and cash equivalents at end of period$189,274$71,494
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest$27,868$34,911
Cash paid for income taxes, net of refunds received$(11)$(460)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.